In both mouse models, we found that supplementation with AHCC prior to and after infection with SARS-CoV-2 decreased viral replication and virus-induced inflammation and pathology in the lung as well as decreasing lethality in K18-hACE2 mice. This evidence concerns the gene KRT18 and infection.